These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70. Circulating tumor DNA as a liquid biopsy target for detection of pancreatic cancer. Takai E; Yachida S World J Gastroenterol; 2016 Oct; 22(38):8480-8488. PubMed ID: 27784960 [TBL] [Abstract][Full Text] [Related]
71. Detection of Minimal Residual Disease and Its Clinical Applications in Melanoma and Breast Cancer Patients. Lin SY; Orozco JIJ; Hoon DSB Adv Exp Med Biol; 2018; 1100():83-95. PubMed ID: 30411261 [TBL] [Abstract][Full Text] [Related]
72. Liquid Biopsy: Approaches to Dynamic Genotyping in Cancer. von Bubnoff N Oncol Res Treat; 2017; 40(7-8):409-416. PubMed ID: 28693026 [TBL] [Abstract][Full Text] [Related]
74. Characterization of single circulating tumor cells. Alix-Panabières C; Pantel K FEBS Lett; 2017 Aug; 591(15):2241-2250. PubMed ID: 28459503 [TBL] [Abstract][Full Text] [Related]
75. The functional and clinical roles of liquid biopsy in patient-derived models. Zhu Z; Hu E; Shen H; Tan J; Zeng S J Hematol Oncol; 2023 Apr; 16(1):36. PubMed ID: 37031172 [TBL] [Abstract][Full Text] [Related]
76. Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook. Tinhofer I; Staudte S Expert Rev Mol Diagn; 2018 Oct; 18(10):897-906. PubMed ID: 30199647 [TBL] [Abstract][Full Text] [Related]
77. Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA. Semenkovich NP; Szymanski JJ; Earland N; Chauhan PS; Pellini B; Chaudhuri AA J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37349125 [TBL] [Abstract][Full Text] [Related]
78. A headlight on liquid biopsies: a challenging tool for breast cancer management. Massihnia D; Perez A; Bazan V; Bronte G; Castiglia M; Fanale D; Barraco N; Cangemi A; Di Piazza F; Calò V; Rizzo S; Cicero G; Pantuso G; Russo A Tumour Biol; 2016 Apr; 37(4):4263-73. PubMed ID: 26790442 [TBL] [Abstract][Full Text] [Related]
79. The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring. Batool SM; Yekula A; Khanna P; Hsia T; Gamblin AS; Ekanayake E; Escobedo AK; You DG; Castro CM; Im H; Kilic T; Garlin MA; Skog J; Dinulescu DM; Dudley J; Agrawal N; Cheng J; Abtin F; Aberle DR; Chia D; Elashoff D; Grognan T; Krysan K; Oh SS; Strom C; Tu M; Wei F; Xian RR; Skates SJ; Zhang DY; Trinh T; Watson M; Aft R; Rawal S; Agarwal A; Kesmodel SB; Yang C; Shen C; Hochberg FH; Wong DTW; Patel AA; Papadopoulos N; Bettegowda C; Cote RJ; Srivastava S; Lee H; Carter BS; Balaj L Cell Rep Med; 2023 Oct; 4(10):101198. PubMed ID: 37716353 [TBL] [Abstract][Full Text] [Related]
80. Cell-free DNA in large B-cell lymphoma: MRD and beyond. Sworder BJ; Kurtz DM Semin Hematol; 2023 Jul; 60(3):142-149. PubMed ID: 37474409 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]